Taiwan · Delayed Price · Currency is TWD Dr. Wu Skincare Statistics
Total Valuation
Dr. Wu Skincare has a market cap or net worth of TWD 5.27 billion. The enterprise value is 4.48 billion.
| Market Cap | 5.27B |
| Enterprise Value | 4.48B |
Important Dates
The last earnings date was Wednesday, March 4, 2026.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | Dec 4, 2025 |
Share Statistics
Dr. Wu Skincare has 45.05 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 45.05M |
| Shares Outstanding | 45.05M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 25.74% |
| Owned by Institutions (%) | 0.75% |
| Float | 14.99M |
Valuation Ratios
The trailing PE ratio is 15.10.
| PE Ratio | 15.10 |
| Forward PE | n/a |
| PS Ratio | 4.51 |
| PB Ratio | 3.89 |
| P/TBV Ratio | 3.89 |
| P/FCF Ratio | 15.73 |
| P/OCF Ratio | 15.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.25, with an EV/FCF ratio of 13.36.
| EV / Earnings | 12.78 |
| EV / Sales | 3.83 |
| EV / EBITDA | 10.25 |
| EV / EBIT | 10.48 |
| EV / FCF | 13.36 |
Financial Position
The company has a current ratio of 5.71, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.71 |
| Quick Ratio | 4.75 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.12 |
| Interest Coverage | 307.25 |
Financial Efficiency
Return on equity (ROE) is 24.93% and return on invested capital (ROIC) is 63.34%.
| Return on Equity (ROE) | 24.93% |
| Return on Assets (ROA) | 15.98% |
| Return on Invested Capital (ROIC) | 63.34% |
| Return on Capital Employed (ROCE) | 30.81% |
| Weighted Average Cost of Capital (WACC) | 4.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.70 |
| Inventory Turnover | 2.20 |
Taxes
In the past 12 months, Dr. Wu Skincare has paid 91.21 million in taxes.
| Income Tax | 91.21M |
| Effective Tax Rate | 20.66% |
Stock Price Statistics
The stock price has decreased by -23.03% in the last 52 weeks. The beta is 0.06, so Dr. Wu Skincare's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -23.03% |
| 50-Day Moving Average | 118.07 |
| 200-Day Moving Average | 124.67 |
| Relative Strength Index (RSI) | 46.77 |
| Average Volume (20 Days) | 35,744 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Wu Skincare had revenue of TWD 1.17 billion and earned 350.27 million in profits. Earnings per share was 7.75.
| Revenue | 1.17B |
| Gross Profit | 805.59M |
| Operating Income | 427.07M |
| Pretax Income | 441.49M |
| Net Income | 350.27M |
| EBITDA | 436.73M |
| EBIT | 427.07M |
| Earnings Per Share (EPS) | 7.75 |
Balance Sheet
The company has 836.03 million in cash and 40.98 million in debt, with a net cash position of 795.05 million or 17.65 per share.
| Cash & Cash Equivalents | 836.03M |
| Total Debt | 40.98M |
| Net Cash | 795.05M |
| Net Cash Per Share | 17.65 |
| Equity (Book Value) | 1.35B |
| Book Value Per Share | 30.14 |
| Working Capital | 962.56M |
Cash Flow
In the last 12 months, operating cash flow was 340.92 million and capital expenditures -5.91 million, giving a free cash flow of 335.01 million.
| Operating Cash Flow | 340.92M |
| Capital Expenditures | -5.91M |
| Free Cash Flow | 335.01M |
| FCF Per Share | 7.44 |
Margins
Gross margin is 68.96%, with operating and profit margins of 36.56% and 29.98%.
| Gross Margin | 68.96% |
| Operating Margin | 36.56% |
| Pretax Margin | 37.79% |
| Profit Margin | 29.98% |
| EBITDA Margin | 37.38% |
| EBIT Margin | 36.56% |
| FCF Margin | 28.68% |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 9.48%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 9.48% |
| Dividend Growth (YoY) | -9.09% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 128.61% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 9.36% |
| Earnings Yield | 6.65% |
| FCF Yield | 6.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 26, 2016. It was a forward split with a ratio of 1.5.
| Last Split Date | May 26, 2016 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |